Human Fibrinogen Concentrate Market Driven by Rising Bleeding Disorders, Growing at 11.3% CAGR by 2035
· heathcare foresights
AI Briefing
- Human fibrinogen concentrate market to grow at 11.3% CAGR by 2035, driven by rising bleeding disorders and demand for hemostatic therapies.
- Increasing usage in surgical procedures and surgical trauma is contributing to the market growth.
- Regulatory approvals for fibrinogen concentrate products in various regions are expected to further fuel market expansion.
Advertisement